Stefka Stoilova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Stefka Stoilova has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Mariela Geneva-Popova
Department of Propaedeutics of Internal Diseases, Faculty of Medicine, Medical University of Plovdiv, 4002 Plovdiv, Bulgaria
3 shared publications Daniela Taneva
2 shared publications- Daniela Taneva
Department of Nursing Care, Medical University Plovdiv, Plovdiv, Bulgaria, Bulgaria
2 shared publications Mariela Geneva-Popova
2 shared publicationsStanislava Popova-Belova
2 shared publications- Dimitar Nikolov
Second Department of Internal Diseases, Faculty of Medicine, Clinic of Nephrology, University Hospital “Sv. George”, Medical University—Plovdiv, 4002 Plovdiv, Bulgaria
1 shared publication
Latest Publications
- Open Access
- 22 April 2026
- Published by MDPI AG in Metabolites
- Vol. 16 (5) , 287
Altered Lipid Metabolism in Psoriatic Arthritis: A Comprehensive Review
Psoriatic arthritis (PsA) is a chronic inflammatory disorder affecting both the joints and skin. Beyond musculoskeletal manifestations, patients with PsA frequently exhibit alterations in lipid metabolism, contributing to an increased risk of cardiovascular disease. Dyslipidemia in PsA arises from multiple mechanisms, including systemic inflammation, insulin resistance, and imbalances in adipokines such as leptin, adiponectin, and resistin. A structured literature search was conducted in PubMed, Scopus, and Web of Science to identify relevant studies on lipid metabolism in psoriatic arthritis, and the evidence was synthesized narratively. PsA is also commonly associated with obesity and metabolic syndrome, further exacerbating dyslipidemia and cardiovascular risk. Interventions including weight loss, lifestyle modification, and anti-inflammatory treatments have been shown to improve lipid profiles and clinical outcomes. This review provides a comprehensive overview of current knowledge on altered lipid metabolism in PsA, highlighting underlying mechanisms, clinical implications, and therapeutic strategies to reduce cardiovascular risk.
- 22 April 2026
- Published by MDPI AG in Metabolites
- Vol. 16 (5) , 287
Open AccessAltered Lipid Metabolism in Psoriatic Arthritis: A Comprehensive Review
Psoriatic arthritis (PsA) is a chronic inflammatory disorder affecting both the joints and skin. Beyond musculoskeletal manifestations, patients with PsA frequently exhibit alterations in lipid metabolism, contributing to an increased risk of cardiovascular disease. Dyslipidemia in PsA arises from multiple mechanisms, including systemic inflammation, insulin resistance, and imbalances in adipokines such as leptin, adiponectin, and resistin. A structured literature search was conducted in PubMed, Scopus, and Web of Science to identify relevant studies on lipid metabolism in psoriatic arthritis, and the evidence was synthesized narratively. PsA is also commonly associated with obesity and metabolic syndrome, further exacerbating dyslipidemia and cardiovascular risk. Interventions including weight loss, lifestyle modification, and anti-inflammatory treatments have been shown to improve lipid profiles and clinical outcomes. This review provides a comprehensive overview of current knowledge on altered lipid metabolism in PsA, highlighting underlying mechanisms, clinical implications, and therapeutic strategies to reduce cardiovascular risk.
- 1 January 2026
- Published by Discovery Medicine in Discovery Medicine
- Vol. 38 (208) , 1327-1342
Inflammatory Low Back Pain Across Inflammatory Joint Diseases: Diagnostic Challenges and Evolving Treatment Strategies
Inflammatory low back pain (IBP) is a key clinical feature of axial spondyloarthritis (axSpA) and an important diagnostic clue in patients presenting with chronic back pain. However, IBP is neither disease-specific nor uniformly expressed across inflammatory joint diseases, and its recognition in routine clinical practice remains challenging. Significant symptom overlap with mechanical low back pain, heterogeneity of clinical presentation, limited specificity of imaging findings, and frequent misuse of classification criteria as diagnostic tools contribute to persistent diagnostic uncertainty and delay. Despite advances in imaging and therapeutics, several critical challenges remain unresolved, including the limited specificity of IBP constructs, the risk of MRI overinterpretation, and the unclear nosological status of axial psoriatic arthritis (axial PsA). Moreover, variability in treatment response across disease phenotypes highlights the need for more precise diagnostic and therapeutic frameworks. This narrative review provides a structured and critical synthesis of current evidence on IBP across inflammatory joint diseases. It emphasizes key diagnostic pitfalls, including imaging-related challenges and misapplication of classification criteria, and highlights disease-specific differences between axSpA, axial PsA, and rheumatoid arthritis. In addition, it outlines clinically relevant considerations for diagnostic evaluation and therapeutic decision-making. Future research should focus on the development of integrated diagnostic models, improved imaging interpretation strategies, and disease-specific therapeutic approaches to optimize patient outcomes.
- 1 January 2026
- Published by Discovery Medicine in Discovery Medicine
- Vol. 38 (208) , 1327-1342
Inflammatory Low Back Pain Across Inflammatory Joint Diseases: Diagnostic Challenges and Evolving Treatment Strategies
Inflammatory low back pain (IBP) is a key clinical feature of axial spondyloarthritis (axSpA) and an important diagnostic clue in patients presenting with chronic back pain. However, IBP is neither disease-specific nor uniformly expressed across inflammatory joint diseases, and its recognition in routine clinical practice remains challenging. Significant symptom overlap with mechanical low back pain, heterogeneity of clinical presentation, limited specificity of imaging findings, and frequent misuse of classification criteria as diagnostic tools contribute to persistent diagnostic uncertainty and delay. Despite advances in imaging and therapeutics, several critical challenges remain unresolved, including the limited specificity of IBP constructs, the risk of MRI overinterpretation, and the unclear nosological status of axial psoriatic arthritis (axial PsA). Moreover, variability in treatment response across disease phenotypes highlights the need for more precise diagnostic and therapeutic frameworks. This narrative review provides a structured and critical synthesis of current evidence on IBP across inflammatory joint diseases. It emphasizes key diagnostic pitfalls, including imaging-related challenges and misapplication of classification criteria, and highlights disease-specific differences between axSpA, axial PsA, and rheumatoid arthritis. In addition, it outlines clinically relevant considerations for diagnostic evaluation and therapeutic decision-making. Future research should focus on the development of integrated diagnostic models, improved imaging interpretation strategies, and disease-specific therapeutic approaches to optimize patient outcomes.
- Open Access
- 8 August 2025
- Published by Springer Nature in BMC Rheumatology
- Vol. 9 (1) , 97
Influence of socio-demographic factors on health-related quality of life in patients with inflammatory joint diseases
This study was conducted to describe differences in self-reported health-related quality of life (HRQoL) for patients with inflammatory joint disease (IJD) related to sociodemographic factors. The data were collected through an anonymous survey in a cross-sectional study of 261 patients with IJD- rheumatoid arthritis (RA), psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA). The patients' health status was assessed using a standard questionnaire [EQ-5D-3L]. The results showed no significant differences related to the type of JDC in any domain of patients' quality of life. Among the demographic factors, social status showed a significant association with all aspects of patients' HRQoL: mobility ratings (p = 0.002), self-care ratings (p < 0.001), usual activities (p < 0.001), pain or discomfort (p = 0.039), anxiety or depression (p = 0.001). Anxiety and depression were more common among women than men (p = 0.033). Men rated their health higher on the EQ-VAS scale (p = 0.036). Working patients reported better health than retirees (p = 0.008), and disability pensioners (p < 0.001). Better health was associated with higher levels of education (p < 0.001). Patients with elementary education provided the lowest ratings while patients with higher degrees gave the highest ratings. Patients living in villages reported better health than those from urban areas (p = 0.019). Social class, education, and place of residence accounted for 17.9% of the variance in EQ-VAS scores. Understanding the role of sociodemographic factors is crucial to promote improved patient care and better healthcare resources. The results of our study can serve as a benchmark for future studies to assess the influence of sociodemographic factors among patients with other subtypes of IJD.
- 8 August 2025
- Published by Springer Nature in BMC Rheumatology
- Vol. 9 (1) , 97
Open AccessInfluence of socio-demographic factors on health-related quality of life in patients with inflammatory joint diseases
This study was conducted to describe differences in self-reported health-related quality of life (HRQoL) for patients with inflammatory joint disease (IJD) related to sociodemographic factors. The data were collected through an anonymous survey in a cross-sectional study of 261 patients with IJD- rheumatoid arthritis (RA), psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA). The patients' health status was assessed using a standard questionnaire [EQ-5D-3L]. The results showed no significant differences related to the type of JDC in any domain of patients' quality of life. Among the demographic factors, social status showed a significant association with all aspects of patients' HRQoL: mobility ratings (p = 0.002), self-care ratings (p < 0.001), usual activities (p < 0.001), pain or discomfort (p = 0.039), anxiety or depression (p = 0.001). Anxiety and depression were more common among women than men (p = 0.033). Men rated their health higher on the EQ-VAS scale (p = 0.036). Working patients reported better health than retirees (p = 0.008), and disability pensioners (p < 0.001). Better health was associated with higher levels of education (p < 0.001). Patients with elementary education provided the lowest ratings while patients with higher degrees gave the highest ratings. Patients living in villages reported better health than those from urban areas (p = 0.019). Social class, education, and place of residence accounted for 17.9% of the variance in EQ-VAS scores. Understanding the role of sociodemographic factors is crucial to promote improved patient care and better healthcare resources. The results of our study can serve as a benchmark for future studies to assess the influence of sociodemographic factors among patients with other subtypes of IJD.
- Open Access
- 3 June 2025
- Published by IntechOpen
Integrative Treatment for Arthritis
Integrative medicine is a holistic approach that focuses on the patient (the person as a whole) rather than the disease; it combines methods of conventional evidence-based medicine with complementary therapies to improve all aspects of health, including physical, mental and spiritual well-being. Leading global organizations recommend the use of both pharmacological and non-pharmacological treatments in the management of arthritis, with the participation of a multidisciplinary team. Recommendations include both medical and non-medical interventions provided by healthcare professionals – nurses, physical therapists (PTs) and occupational therapists (OTs). The implementation of integrative interventions for arthritis management, such as exercise, rehabilitation and diet, as well as the assessment of educational needs, provision of psychosocial support and encouragement of self-management, complement pharmacological treatment and involve patients in shared decision-making in arthritis care.
- 3 June 2025
- Published by IntechOpen
Open AccessIntegrative Treatment for Arthritis
Integrative medicine is a holistic approach that focuses on the patient (the person as a whole) rather than the disease; it combines methods of conventional evidence-based medicine with complementary therapies to improve all aspects of health, including physical, mental and spiritual well-being. Leading global organizations recommend the use of both pharmacological and non-pharmacological treatments in the management of arthritis, with the participation of a multidisciplinary team. Recommendations include both medical and non-medical interventions provided by healthcare professionals – nurses, physical therapists (PTs) and occupational therapists (OTs). The implementation of integrative interventions for arthritis management, such as exercise, rehabilitation and diet, as well as the assessment of educational needs, provision of psychosocial support and encouragement of self-management, complement pharmacological treatment and involve patients in shared decision-making in arthritis care.
- Open Access
- 5 September 2024
- Published by Pensoft Publishers in Pharmacia
- Vol. 71, 1-7
Treatment with biologics of patients with inflammatory joint diseases
Over the past two decades, biologics (Bs) have been widely used in the treatment of patients with inflammatory joint diseases (IJD). The treatment of IJD aims at reducing disease progression, improving patients’ physical health and well-being, and achieving long-lasting remission or, at least, minimal disease activity. The introduction of Bs in rheumatology practice has significantly improved patients’ outcomes and prognosis. Their use, however, involves undertaking significant risks and challenges for both patients and medical teams. The purpose of this article is to provide a brief overview of the biological therapies currently approved for this group of diseases in Bulgaria and the indications for administration and monitoring of the most common side effects. The optimal administration of Bs is determined by treatment efficacy, discussion of benefits and risks, prevention of the possible development of severe adverse effects, administration regimens, and routes of administration of Bs. The analysis of major issues during treatment helps summarize the information on the use of Bs, thus increasing the possibility of managing the risks associated with their use by strengthening the engagement of healthcare experts and patients in the process of monitoring the impact of biological agents.
- 5 September 2024
- Published by Pensoft Publishers in Pharmacia
- Vol. 71, 1-7
Open AccessTreatment with biologics of patients with inflammatory joint diseases
Over the past two decades, biologics (Bs) have been widely used in the treatment of patients with inflammatory joint diseases (IJD). The treatment of IJD aims at reducing disease progression, improving patients’ physical health and well-being, and achieving long-lasting remission or, at least, minimal disease activity. The introduction of Bs in rheumatology practice has significantly improved patients’ outcomes and prognosis. Their use, however, involves undertaking significant risks and challenges for both patients and medical teams. The purpose of this article is to provide a brief overview of the biological therapies currently approved for this group of diseases in Bulgaria and the indications for administration and monitoring of the most common side effects. The optimal administration of Bs is determined by treatment efficacy, discussion of benefits and risks, prevention of the possible development of severe adverse effects, administration regimens, and routes of administration of Bs. The analysis of major issues during treatment helps summarize the information on the use of Bs, thus increasing the possibility of managing the risks associated with their use by strengthening the engagement of healthcare experts and patients in the process of monitoring the impact of biological agents.
- Open Access
- 25 March 2024
- Published by IntechOpen
Perspective chapter: NURSE-LED EDUCATION FOR PATIENTS WITH CHRONIC INFLAMMATORY ARTHRITIS
As an integral part of disease monitoring and management of patients with chronic inflammatory arthritis, patient education is highly recommended to help patients optimize their health and well-being rather than be limited to the disease. Rheumatology nurses have been shown to play a major role in patient education, thus enabling them to increase their knowledge about their health condition as well as change their health behavior. Since patients with chronic inflammatory arthritis have different educational needs, patient education can be provided in a variety of ways tailored to the specific and unique needs of each patient. The extent to which nurses in various regions of the world are involved in patient education depends on both their professional background and the organization of the relevant health system.
- 25 March 2024
- Published by IntechOpen
Open AccessPerspective chapter: NURSE-LED EDUCATION FOR PATIENTS WITH CHRONIC INFLAMMATORY ARTHRITIS
As an integral part of disease monitoring and management of patients with chronic inflammatory arthritis, patient education is highly recommended to help patients optimize their health and well-being rather than be limited to the disease. Rheumatology nurses have been shown to play a major role in patient education, thus enabling them to increase their knowledge about their health condition as well as change their health behavior. Since patients with chronic inflammatory arthritis have different educational needs, patient education can be provided in a variety of ways tailored to the specific and unique needs of each patient. The extent to which nurses in various regions of the world are involved in patient education depends on both their professional background and the organization of the relevant health system.
- Open Access
- 30 April 2023
- Published by Pensoft Publishers in Folia Medica
- Vol. 65 (2) , 235-242
Accessibility to and awareness of rheumatology care provided by a nurse - a pilot study
Introduction: Good medical care depends both on the access to specialists and awareness of patients and healthcare professionals. Aim: The purpose of this study was to assess the accessibility to rheumatology outpatient care and the awareness of patients with inflammatory joint diseases with regard to the types of sources and preferences of sources for obtaining information related to their disease and treatment, as well as to establish the extent to which this information is useful to patients. Materials and methods: A pilot, cross-sectional, single center, anonymous study was conducted among adult patients with inflammatory joint diseases who were monitored in an outpatient rheumatology room at St George Diagnostic and Consultative Center in Plovdiv. A total of 56 patients were monitored. The questionnaire contained 56 questions, divided into 5 main groups: 1. questions about the disease, 2. questions about the sociodemographic profile of the patients, 3. questions about accessibility to specialized healthcare, 4. questions about the role of the nurse in the training of patients with inflammatory joint disease, and 5. questions evaluating the attitude to the monitoring medical team. The data were analyzed with IBM SPSS V.26, at a statistical significance level of pResults: Women predominated among the patients under observation (37, 66%), as well as patients in the age group of 50-79 years (46, 82%). Twenty-four (42.9%) were the patients attending the consulting room twice a year. On-the-spot booking in the consulting room was preferred mainly among patients who lived within 50 km (3/16, 19%), while the rest of the patients preferred booking appointments by phone. Forty-five (80%) patients of the total number of patients used subcutaneous biological agents. Among them, the patients whose first application was performed by a nurse in a rheumatology room predominated (44 patients, 96%). All respondents (56, 100%) indicated that they had received self-injection training from a healthcare professional. Conclusion: Patients with inflammatory joint diseases need information to help them manage issues related to their disease and treatment, as well as cope with their physical and psychological needs. Our study shows that patients most commonly use a combination of information sources – they get information from a doctor or from a healthcare professional, i.e. a nurse. We highlighted in the study the crucial role of nurses in improving the access of patients to specialized rheumatology care and satisfying patients’ information needs.
- 30 April 2023
- Published by Pensoft Publishers in Folia Medica
- Vol. 65 (2) , 235-242
Open AccessAccessibility to and awareness of rheumatology care provided by a nurse - a pilot study
Introduction: Good medical care depends both on the access to specialists and awareness of patients and healthcare professionals. Aim: The purpose of this study was to assess the accessibility to rheumatology outpatient care and the awareness of patients with inflammatory joint diseases with regard to the types of sources and preferences of sources for obtaining information related to their disease and treatment, as well as to establish the extent to which this information is useful to patients. Materials and methods: A pilot, cross-sectional, single center, anonymous study was conducted among adult patients with inflammatory joint diseases who were monitored in an outpatient rheumatology room at St George Diagnostic and Consultative Center in Plovdiv. A total of 56 patients were monitored. The questionnaire contained 56 questions, divided into 5 main groups: 1. questions about the disease, 2. questions about the sociodemographic profile of the patients, 3. questions about accessibility to specialized healthcare, 4. questions about the role of the nurse in the training of patients with inflammatory joint disease, and 5. questions evaluating the attitude to the monitoring medical team. The data were analyzed with IBM SPSS V.26, at a statistical significance level of pResults: Women predominated among the patients under observation (37, 66%), as well as patients in the age group of 50-79 years (46, 82%). Twenty-four (42.9%) were the patients attending the consulting room twice a year. On-the-spot booking in the consulting room was preferred mainly among patients who lived within 50 km (3/16, 19%), while the rest of the patients preferred booking appointments by phone. Forty-five (80%) patients of the total number of patients used subcutaneous biological agents. Among them, the patients whose first application was performed by a nurse in a rheumatology room predominated (44 patients, 96%). All respondents (56, 100%) indicated that they had received self-injection training from a healthcare professional. Conclusion: Patients with inflammatory joint diseases need information to help them manage issues related to their disease and treatment, as well as cope with their physical and psychological needs. Our study shows that patients most commonly use a combination of information sources – they get information from a doctor or from a healthcare professional, i.e. a nurse. We highlighted in the study the crucial role of nurses in improving the access of patients to specialized rheumatology care and satisfying patients’ information needs.